AIGH Capital Management’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History

AIGH Capital Management’s Portfolio CYTHW Stock Details CYTHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-270,274	Closed	-$141K	–	62
2022 Q4	$141K	Buy	270,274 +196,538	+267%	+$116K	0.05%	47
2022 Q3	$26K	Sell	73,736 -220,695	-75%	-$114K	0.01%	52
2022 Q2	$38K	Sell	294,431 -500	-0.2%	-$489	0.01%	46
2022 Q1	$935K	Hold	294,931	–	–	0.23%	38
2021 Q4	$1.1M	Buy	+294,931	New	+$711K	0.34%	43
2021 Q3	–	Sell	-350,000	Closed	-$1.81M	–	59
2021 Q2	$1.81M	Buy	+350,000	New	+$1.29M	0.33%	43

Other funds holding CYTHW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIGH Capital Management's CYTHW Position: Q4 2022 in Review

AIGH Capital Management sold out of Cyclo Therapeutics, Inc. Warrant (CYTHW) in Q4 2022, closing a stake of 219,795 shares — an estimated $130K sold.

AIGH Capital Management first reported a position in CYTHW in Q4 2020 and held it in 2 quarters. The position peaked at $1.52M in Q4 2020. 3 funds tracked by Wall St. Rank hold CYTHW as of Q4 2022.

AIGH Capital Management reported no remaining Cyclo Therapeutics, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
AIGH Capital Management sold 219,795 Cyclo Therapeutics, Inc. Warrant shares in Q4 2022, an estimated $130K.
AIGH Capital Management first reported a position in Cyclo Therapeutics, Inc. Warrant in Q4 2020 and held it in 2 quarters.
AIGH Capital Management's Cyclo Therapeutics, Inc. Warrant position peaked at $1.52M in Q4 2020.
3 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q4 2022.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.